The EMRA offices will be closed for the upcoming holidays from Tuesday, December 24, 2024 thru Wednesday, January 1, 2025. We apologize for the inconvenience.
Can methylene blue play a role in treating your patient with septic shock? This randomized control trial shows earlier vasopressor discontinuation and shorter ICU and hospital lengths of stay - but no
In a recent study, fludrocortisone added to hydrocortisone was associated with increased hospital survival, shorter hospital lengths of stay, and decreased vasopressor duration when compared to hydroc
Critical Care Alert: The triage of patients in the trauma bay is difficult, and no single measurement or vital sign will provide sufficient information for mortality. This study indicates ETCO2 - a co
Two recent papers offer insight into the use of peripheral IVs to administer vasopressors. Will these studies change your practice for critically ill patients in the emergency department?
Fluid overload has not been clearly defined in the critical care arena. In situations where patients have renal, cardiac, and pulmonary dysfunction, commonly seen in the ICU, large volume fluid therap
About 1 in 5 patients with hypertrophic cardiomyopathy will develop atrial fibrillation. Here's how to clue in to this underlying cause of the dysrhythmia when a patient presents to you in the ED.
The use of exogenous steroids in septic shock is a controversial issue with inconsistent data on mortality to date. Several studies examine sepsis treatment. What does the evidence show?
Diagnosing and Managing Shock
From the March 2014 issue of Emergency Medicine Practice, “Diagnosis and Management of Shock in the Emergency Department.” Reprinted with permission. To access your EMRA
Comparison of Dopamine and Norepinephrine in the Treatment of Shock
This Critical Care Alert from EMRA's Critical Care Division did not appear in the print version of EM Resident Magazine. Learn more